At the Intersection of Harm Reduction and COVID-19: The Role of Anthropologists during and Post-Pandemic

被引:0
作者
Harris, Shana [1 ,2 ]
Schlosser, Allison [3 ]
机构
[1] Univ Cent Florida, Dept Anthropol, Orlando, FL 32816 USA
[2] Univ Cent Florida, Dept Internal Med, Orlando, FL 32816 USA
[3] Univ Nebraska, Med Anthropol, Omaha, NE USA
关键词
COVID-19; drug use; harm reduction; health policy; United States; SUBSTANCE USE DISORDERS; OPIOID USE DISORDER;
D O I
暂无
中图分类号
Q98 [人类学];
学科分类号
030303 ;
摘要
Harm reduction is a public health approach that emphasizes reducing the negative effects of drug use rather than eliminating it. It has been practiced for decades; however, the COVID-19 pandemic poses new challenges for people who use drugs (PWUD) and harm reduction providers. In the United States, public health recommendations to curb the pandemic are complicating harm reduction efforts. Harm reduction programs are rethinking how they engage with PWUD to comply with these recommendations while also providing essential services. In this article, we draw on academic literature, news articles, and information distributed by harm reduction programs to discuss issues currently faced by PWUD and harm reduction providers across the country. This discussion focuses on policy changes and programming adaptations related to three harm reduction interventions-syringe services programs, overdose prevention, and medications for opioid use disorder-that have emerged or gained traction during the pandemic. We argue that anthropologists should play a key role in addressing the obstacles and opportunities for harm reduction in the United States during and post-pandemic. Ethnographic research can generate important knowledge of how pandemic-related service and policy changes are localized by providers and experienced by PWUD and uncover how race, class, and gender may shape access to and experiences with modified harm reduction services. Applied anthropologists also have an important role in collaborating with harm reduction programs to ensure that the voices of marginalized individuals are not ignored as policy and programming changes take place during and after the pandemic.
引用
收藏
页码:272 / 281
页数:10
相关论文
共 53 条
  • [1] [Anonymous], 2022, PROVISIONAL DRUG OVE
  • [2] An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19
    Alexander, G. Caleb
    Stoller, Kenneth B.
    Haffajee, Rebecca L.
    Saloner, Brendan
    [J]. ANNALS OF INTERNAL MEDICINE, 2020, 173 (01) : 57 - +
  • [3] American Psychological Association, 2021, TEL GUID STAT COVID
  • [4] [Anonymous], 1998, HDB METHODS CULTURAL
  • [5] Syringe services program (SSP) operational changes during the COVID-19 global outbreak
    Bartholomew, Tyler S.
    Nakamura, Nobuyo
    Metsch, Lisa R.
    Tookes, Hansel E.
    [J]. INTERNATIONAL JOURNAL OF DRUG POLICY, 2020, 83
  • [6] When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis
    Becker, William C.
    Fiellin, David A.
    [J]. ANNALS OF INTERNAL MEDICINE, 2020, 173 (01) : 59 - +
  • [7] Online recovery support meetings can help mitigate the public health consequences of COVID-19 for individuals with substance use disorder
    Bergmann, Brandon G.
    Kelly, John F.
    Fava, Maurizio
    Evins, A. Eden
    [J]. ADDICTIVE BEHAVIORS, 2021, 113
  • [8] Implementation of a medical student-run telemedicine program for medications for opioid use disorder during the COVID-19 pandemic
    Castillo, Marcus
    Conte, Brianna
    Hinkes, Sam
    Mathew, Megan
    Na, C. J.
    Norindr, Ainhoa
    Serota, David P.
    Forrest, David W.
    Deshpande, Amar R.
    Bartholomew, Tyler S.
    Tookes, Hansel E.
    [J]. HARM REDUCTION JOURNAL, 2020, 17 (01)
  • [9] CDC, 2020, SOC DIST KEEP YOUR D
  • [10] No "back to normal" after COVID-19 for our failed drug policies
    del Pozo, Brandon
    Beletsky, Leo
    [J]. INTERNATIONAL JOURNAL OF DRUG POLICY, 2020, 83